MOLLI Surgical, an innovator in surgical care, has introduced OncoPen™, a tool aimed at empowering surgeons and improving outcomes for patients battling breast cancer. 

This sleek, pen-like wand seamlessly integrates with the acclaimed MOLLI® 2 System, providing sophisticated tools for precisely targeting and removing cancerous lesions. OncoPen represents a significant advancement in minimally invasive breast surgery, offering surgeons unparalleled directional 3D guidance and eliminating the need for wires, thus enhancing scheduling flexibility and patient experience.

Dr. Jaime Alberty, Director of The Comprehensive Breast Center at NYC Health + Hospitals/Kings County, expressed excitement about MOLLI Surgical's innovations in breast cancer surgery, stating, "The OncoPen is truly exciting. The pen-like design complements our workflow seamlessly, further enhancing the capabilities of the MOLLI 2 System. This combination boosts my confidence in our ability to tackle cancer with unmatched precision. It's not just about technology; these tools empower us to deliver effective and compassionate care."

With the increasing prevalence of breast cancer, there is a growing need for advancements in minimally invasive and patient-centric surgical techniques. OncoPen, designed for use with the MOLLI 2 System's advanced navigation capabilities, addresses this critical need.

Ananth Ravi, President and CEO of MOLLI Surgical, emphasized the company's unwavering focus on patient well-being, stating, "At MOLLI Surgical, our relentless focus is on the patient, placing their well-being at the core of all our efforts. We've dedicated ourselves to solving real clinical challenges, driven by a commitment to making a tangible difference in patient care. We're profoundly grateful for the opportunity to improve the patient experience and continue to advance the field of surgical oncology with our innovations."

Louise Temerty, breast cancer survivor and board member of MOLLI Surgical, provided a personal perspective, stating, "From the beginning, enhancing the patient experience with innovative surgical tools has been our guiding star. The OncoPen exemplifies this, leaving no scar behind – a symbol of our dedication to not just physical recovery, but emotional well-being too."

OncoPen marks an advancement in MOLLI Surgical's commitment to improving surgical accuracy while ensuring procedures are less invasive and enhance the patient experience.

With the OncoPen currently available, MOLLI Surgical is poised to make a substantial impact on how cancer surgeries are performed, promising a brighter future for patients and surgeons alike.